The Future of Induced Pluripotent Stem Cells

Report Code: BIO203A

|

April 2020

Induced Pluripotent Stem Cells (iPSCs) hold promising hope for therapeutic solutions for diseases without ethical issues. We’ve seen the first human iPSC clinical trials back in August of 2014, and we’re expecting to see more clinical trials being launched for a variety of diseases. This will propel the progress being made towards opening clinical practices which in turn will drive the growth of both the clinical and the research markets.

Continue reading this report plus more!

Monthly Access $9.99

  • Access to our Library of published and upcoming White Papers
  • Access to thousands of select free reports from publishers such as Barnes Reports, Datassential, TBRC, Verified Market Research, & Primary Research Group
  • Exclusive discounts on full length reports from BCC Research & various additional publishers
  • Cancel at anytime

Single Paper $59.99

  • One Time Purchase
  • Downloadable PDF